| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Clayton Foundation Laboratories for Peptide Biology, The Salk Institute La Jolla, California 92037
Address requests for reprints to: Dr. Wylie Vale, Peptide Biology Laboratory, The Salk Institute, P.O. Box 85800, San Diego, California 92138.
Abstract
The proliferative and differentiating effects of the gonadal hormones inhibin and activin-A were examined on cell lines derived from the ovary and testis. Activin-A was found to inhibit the growth of CHO-K1 (Chinese hamster ovary) cells in culture, with an IC50 of 3 ng/ml. The maximal response (50% inhibition) required 3 days of incubation in the presence of 40 ng/ml activin-A, and the inhibitory effect was accompanied by morphological changes. Inhibin (10 ng/ml) partially blocked the inhibition of growth by activin. Transforming growth factor-β (TGFβ), which is structurally related to activin and inhibin, was a very potent inhibitor of the proliferation of CHO-Kl cells, with an ICB0 of 0.2 ng/ml and a maximal effect (70% inhibition) at 2 ng/ml. The combination of high concentrations of both TGFβ and activin-A did not result in a greater inhibitory effect than that observed with TGFβ alone, suggesting an overlapping step in the mechanism of action for both factors.
In contrast to the results with CHO-Kl cells, differential effects of activin-A and TGFβ were observed in R2C (rat Leydig cell testicular tumor) cells. Activin-A had only a slight effect on proliferation over a 4-day incubation, but inhibited progesterone accumulation in a concentration-dependent fashion within 12 h. TGFβ, on the other hand, was a potent inhibitor of both growth and steroidogenesis in R2C cells.
These studies suggest that activin-A and inhibin may regulate proliferation as well as functions of gonadal cells.
Footnotes
* This work was supported by the Consejo Superior de Investigaciones Centificas (Madrid, Spain) and NIH Program Project Grant HD-13527. Research was conducted in part by the Clayton Foundation for Research, California Division.
Clayton Foundation Investigator.
Received April 17, 1989.
This article has been cited by other articles:
![]() |
S. L. Mellor, E. M. A. Ball, A. E. O'Connor, J.-F. Ethier, M. Cranfield, J. F. Schmitt, D. J. Phillips, N. P. Groome, and G. P. Risbridger Activin {beta}C-Subunit Heterodimers Provide a New Mechanism of Regulating Activin Levels in the Prostate Endocrinology, October 1, 2003; 144(10): 4410 - 4419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Funaba, T. Ikeda, K. Ogawa, M. Murakami, and M. Abe Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration J. Leukoc. Biol., June 1, 2003; 73(6): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Duleba, T. Pehlivan, R. Carbone, and R. Z. Spaczynski Activin Stimulates Proliferation of Rat Ovarian Thecal-Interstitial Cells Biol Reprod, September 1, 2001; 65(3): 704 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, H. Sun, D. C. Danila, S. R. Johnson, D. P. Sigai, X. Zhang, and A. Klibanski Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling Mol. Endocrinol., December 1, 2000; 14(12): 2066 - 2075. [Abstract] [Full Text] |
||||
![]() |
S. C. Cipriano, L. Chen, T. R. Kumar, and M. M. Matzuk Follistatin Is a Modulator of Gonadal Tumor Progression and the Activin-Induced Wasting Syndrome in Inhibin-Deficient Mice Endocrinology, July 1, 2000; 141(7): 2319 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ni, S. Luo, T. Minegishi, and C. Peng Activin A in JEG-3 Cells: Potential Role as an Autocrine Regulator of Steroidogenesis in Humans Biol Reprod, May 1, 2000; 62(5): 1224 - 1230. [Abstract] [Full Text] |
||||
![]() |
Expression of Prolactin-Releasing Peptide and Its Receptor Messenger Ribonucleic Acid in Normal Human Pituitary and Pituitary Adenomas J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4652 - 4655. [Abstract] [Full Text] |
||||
![]() |
H. Mizunuma, X. Liu, K. Andoh, Y. Abe, J. Kobayashi, K. Yamada, H. Yokota, Y. Ibuki, and Y. Hasegawa Activin from Secondary Follicles Causes Small Preantral Follicles to Remain Dormant at the Resting Stage Endocrinology, January 1, 1999; 140(1): 37 - 42. [Abstract] [Full Text] |
||||
![]() |
A. Ishisaki, K. Yamato, A. Nakao, K. Nonaka, M. Ohguchi, P. ten Dijke, and T. Nishihara Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells J. Biol. Chem., September 18, 1998; 273(38): 24293 - 24296. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lejeune, F. Chuzel, P. Sanchez, P. Durand, J. P. Mather, and J. M. Saez Stimulating Effect of Both Human Recombinant Inhibin A and Activin A on Immature Porcine Leydig Cell Functions in Vitro Endocrinology, November 1, 1997; 138(11): 4783 - 4791. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamato, T. Koseki, M. Ohguchi, M. Kizaki, Y. Ikeda, and T. Nishihara Activin A Induction of Cell-Cycle Arrest Involves Modulation of Cyclin D2 and p21CIP1/WAF1 in Plasmacytic Cells Mol. Endocrinol., July 1, 1997; 11(8): 1044 - 1052. [Abstract] [Full Text] |
||||
![]() |
J. W. M. Martens, J. P. de Winter, M. A. Timmerman, A. McLuskey, R. H. N. van Schaik, A. P. N. Themmen, and F. H. de Jong Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells Endocrinology, July 1, 1997; 138(7): 2928 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas, T. Takumi, H. Y. Lin, and H. F. Lodish GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A J. Biol. Chem., January 13, 1995; 270(2): 765 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Albano, N Groome, and J. Smith Activins are expressed in preimplantation mouse embryos and in ES and EC cells and are regulated on their differentiation Development, January 2, 1993; 117(2): 711 - 723. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |